Expression of PPAR'lambda', PPAR'lambda'2, SUR1 and KIR6.2 mRNAin peripheral blood cell in DM 2 patients treated with pioglitazone (2009)
- Authors:
- Hirata, Mario Hiroyuki
- Marques, Milano Felipe dos Santos Ferreira
- Himelfarb, Silvia Tchernin
- Silva, F. A.
- Monaco, Maria Isabel del - Instituto Dante Pazzanese de Cardiologia (IDPC)
- Sampaio, M. P. - Instituto Dante Pazzanese de Cardiologia (IDPC)
- Dinkhuysen, J. F. - Instituto Dante Pazzanese de Cardiologia (IDPC)
- Bertolami, Marcelo Chiara - Instituto Dante Pazzanese de Cardiologia (IDPC)
- Armaganijan, Dikran - Instituto Dante Pazzanese de Cardiologia (IDPC)
- Silva, Valéria Ferreira da - Instituto Dante Pazzanese de Cardiologia (IDPC)
- Rodrigues, Alice Cristina
- Hirata, Rosario Dominguez Crespo
- Hirata, Mario Hiroyuki
- USP affiliated authors: HIRATA, MARIO HIROYUKI - FCF ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF
- Unidade: FCF
- Subjects: DIABETES MELLITUS; POLIMORFISMO
- Language: Inglês
- Imprenta:
- Publisher: American Association for Clinical Chemistry
- Publisher place: Washington
- Date published: 2009
- Source:
- Título: Clinical Chemistry
- ISSN: 1530-8561
- Volume/Número/Paginação/Ano: v. 55, n. 6 suppl., p. A222-A223 res. E-39, 2009
- Conference titles: Annual Meeting of the American Association for Clinical Chemistry
-
ABNT
HIRATA, Mario Hiroyuki et al. Expression of PPAR'lambda', PPAR'lambda'2, SUR1 and KIR6.2 mRNAin peripheral blood cell in DM 2 patients treated with pioglitazone. Clinical Chemistry. Washington: American Association for Clinical Chemistry. . Acesso em: 20 abr. 2026. , 2009 -
APA
Hirata, M. H., Marques, M. F. dos S. F., Himelfarb, S. T., Silva, F. A., Monaco, M. I. del, Sampaio, M. P., et al. (2009). Expression of PPAR'lambda', PPAR'lambda'2, SUR1 and KIR6.2 mRNAin peripheral blood cell in DM 2 patients treated with pioglitazone. Clinical Chemistry. Washington: American Association for Clinical Chemistry. -
NLM
Hirata MH, Marques MF dos SF, Himelfarb ST, Silva FA, Monaco MI del, Sampaio MP, Dinkhuysen JF, Bertolami MC, Armaganijan D, Silva VF da, Rodrigues AC, Hirata RDC. Expression of PPAR'lambda', PPAR'lambda'2, SUR1 and KIR6.2 mRNAin peripheral blood cell in DM 2 patients treated with pioglitazone. Clinical Chemistry. 2009 ; 55( 6 suppl.): A222-A223 res. E-39.[citado 2026 abr. 20 ] -
Vancouver
Hirata MH, Marques MF dos SF, Himelfarb ST, Silva FA, Monaco MI del, Sampaio MP, Dinkhuysen JF, Bertolami MC, Armaganijan D, Silva VF da, Rodrigues AC, Hirata RDC. Expression of PPAR'lambda', PPAR'lambda'2, SUR1 and KIR6.2 mRNAin peripheral blood cell in DM 2 patients treated with pioglitazone. Clinical Chemistry. 2009 ; 55( 6 suppl.): A222-A223 res. E-39.[citado 2026 abr. 20 ] - Ultrassequenciamento exômico dos genes LDLR, APOB, PCSK9 e APOE em pacientes com hipercolesterolemia familiar
- miR-183-5P e miR-421 como biomarcadores epigenéticos precoces da Síndrome Metabólica
- Involvement of TLR2 and TLR4, Chlamydophila pneumoniae and mycoplasma pneumoniae in adventitial inflammation of aortic atherosclerotic aneurysm
- Interferon-'alfa' receptor 1 mRNA expression in peripheral blood mononuclear cells is associated with response to interferon-a therapy of patients with chronic hepatitis C
- Atorvastatina regula negativamente la expresión de microRNAs en individuos hipercolesterolémicos
- IL-6 -174G>C gene polymorphism can be a marker of type 2 diabetes mellitus
- Effects of pioglitazone on total PPARG, PPARG2, SUR1 and KIR6.2 mRNA expression in peripheral blood leukocytes from individuals with type 2 diabetes mellitus
- Alteração da expressão dos transportadores do tipo ABC e SLC no estado hiperlipidêmico e após tratamento com atorvastatina
- Expression of ppargamma, ppargamma2, SUR1 and KIR6.2 MRNA peripheral blood leukocytes and adipose tissue in Type 2 Diabetes mellitus patients trated with pioglitazone
- Reconhecimento do receptor recombinante de ifn 'ALFA' / 'BETA' humano por anticorpos policlonais de coelho
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
